Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 14,739 | 25,459 | 28,533 | 12,367 | 5,972 |
| Operating Income | -14,739 | -25,459 | -28,533 | -12,367 | -5,972 |
| Interest Expense | 0 | 0 | 0 | 0 | -21 |
| Other Income | 794 | 1,238 | 353 | -111 | 0 |
| Pre-tax Income | -13,945 | -24,221 | -28,180 | -12,478 | -5,951 |
| Income Tax | N/A | N/A | -534 | N/A | N/A |
| Net Income Continuous | -13,945 | -24,221 | -27,646 | -12,478 | -5,951 |
| Net Income | $-13,945 | $-24,221 | $-27,646 | $-12,478 | $-5,951 |
| EPS Basic Total Ops | -3.12 | -8.24 | -9.68 | -4.80 | -3.52 |
| EPS Basic Continuous Ops | -3.11 | -8.25 | -9.72 | -4.81 | -3.48 |
| EPS Diluted Total Ops | -3.12 | -8.24 | -9.68 | -4.80 | -3.52 |
| EPS Diluted Continuous Ops | -3.11 | -8.25 | -9.72 | -4.81 | -3.48 |
| EPS Diluted Before Non-Recurring Items | -3.44 | -8.24 | -9.68 | -4.80 | -94.72 |
| EBITDA(a) | $-14,686 | $-25,392 | $-28,475 | $-12,333 | $-5,948 |